NI201100011A - Derivados de piridino - piridinonas, su preparación y su aplicación en terapéutica. - Google Patents

Derivados de piridino - piridinonas, su preparación y su aplicación en terapéutica.

Info

Publication number
NI201100011A
NI201100011A NI201100011A NI201100011A NI201100011A NI 201100011 A NI201100011 A NI 201100011A NI 201100011 A NI201100011 A NI 201100011A NI 201100011 A NI201100011 A NI 201100011A NI 201100011 A NI201100011 A NI 201100011A
Authority
NI
Nicaragua
Prior art keywords
therapeutics
preparation
pyridinones
application
pyridine derivatives
Prior art date
Application number
NI201100011A
Other languages
English (en)
Inventor
Bellevergue Patrice
Lassalle Gilbert
Mccort Gary
Martin Valérie
Savi Pierre
Volle-Challier Cécile
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of NI201100011A publication Critical patent/NI201100011A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings

Abstract

La invención se refiere a los derivados de piridino-piridinonas, de fórmula general (I): en la que R1, R2, R3, R4, R5, R6, R7, V, W, Y, Z, m son tales como se han definido en la descripción. Procedimiento de preparación y aplicación en terapéutica.
NI201100011A 2008-07-08 2011-01-07 Derivados de piridino - piridinonas, su preparación y su aplicación en terapéutica. NI201100011A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0803862A FR2933700B1 (fr) 2008-07-08 2008-07-08 Derives de pyridino-pyridinones, leur preparation et leur application en therapeutique

Publications (1)

Publication Number Publication Date
NI201100011A true NI201100011A (es) 2011-08-05

Family

ID=40219672

Family Applications (1)

Application Number Title Priority Date Filing Date
NI201100011A NI201100011A (es) 2008-07-08 2011-01-07 Derivados de piridino - piridinonas, su preparación y su aplicación en terapéutica.

Country Status (32)

Country Link
US (1) US8436011B2 (es)
EP (1) EP2315767B1 (es)
JP (1) JP5606434B2 (es)
KR (1) KR20110031372A (es)
CN (1) CN102149713B (es)
AR (1) AR072798A1 (es)
AU (1) AU2009267827B2 (es)
BR (1) BRPI0915438A2 (es)
CA (1) CA2729833A1 (es)
CL (1) CL2011000048A1 (es)
CO (1) CO6341476A2 (es)
CR (1) CR11866A (es)
DO (1) DOP2011000008A (es)
EA (1) EA019362B1 (es)
EC (1) ECSP11010742A (es)
ES (1) ES2438540T3 (es)
FR (1) FR2933700B1 (es)
HK (1) HK1159108A1 (es)
HN (1) HN2011000076A (es)
IL (1) IL210514A (es)
MA (1) MA32544B1 (es)
MX (1) MX2011000330A (es)
MY (1) MY149705A (es)
NI (1) NI201100011A (es)
NZ (1) NZ590862A (es)
PE (1) PE20110405A1 (es)
SV (1) SV2011003800A (es)
TW (1) TW201004955A (es)
UA (1) UA102858C2 (es)
UY (1) UY31971A (es)
WO (1) WO2010004197A2 (es)
ZA (1) ZA201100210B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0205455D0 (en) 2002-03-07 2002-04-24 Molecular Sensing Plc Nucleic acid probes, their synthesis and use
FR2933700B1 (fr) 2008-07-08 2010-07-30 Sanofi Aventis Derives de pyridino-pyridinones, leur preparation et leur application en therapeutique
FR2952934B1 (fr) 2009-11-23 2012-06-22 Sanofi Aventis Derives de pyridino-pyridinones, leur preparation et leur application en therapeutique
FR2954943B1 (fr) * 2010-01-07 2013-03-01 Sanofi Aventis Derives de pyridino-pyridinones arylsulfonamides, leur preparation et leur application en therapeutique
FR2955109B1 (fr) * 2010-01-08 2012-09-07 Sanofi Aventis Derives de 5-oxo-5,8-dihydro-pyrido[2, 3-d]pyrimidine, leur preparation et leur application en therapeutique
US9526648B2 (en) 2010-06-13 2016-12-27 Synerz Medical, Inc. Intragastric device for treating obesity
US8628554B2 (en) 2010-06-13 2014-01-14 Virender K. Sharma Intragastric device for treating obesity
US10420665B2 (en) 2010-06-13 2019-09-24 W. L. Gore & Associates, Inc. Intragastric device for treating obesity
US10010439B2 (en) 2010-06-13 2018-07-03 Synerz Medical, Inc. Intragastric device for treating obesity
EP2524915A1 (en) 2011-05-20 2012-11-21 Sanofi 2-Amino-3-(imidazol-2-yl)-pyridin-4-one derivatives and their use as VEGF receptor kinase inhibitors
HUE035712T2 (en) * 2012-07-17 2018-05-28 Sanofi Sa Use of Vegfr-3 inhibitors for the treatment of hepatocellular carcinoma
UA110688C2 (uk) * 2012-09-21 2016-01-25 Пфайзер Інк. Біциклічні піридинони
US10779980B2 (en) 2016-04-27 2020-09-22 Synerz Medical, Inc. Intragastric device for treating obesity
JP2018052878A (ja) * 2016-09-29 2018-04-05 第一三共株式会社 ピリジン化合物
WO2019099314A1 (en) 2017-11-14 2019-05-23 Merck Sharp & Dohme Corp. Novel substituted biaryl compounds as indoleamine 2,3-dioxygenase (ido) inhibitors
WO2019099294A1 (en) 2017-11-14 2019-05-23 Merck Sharp & Dohme Corp. Novel substituted biaryl compounds as indoleamine 2,3-dioxygenase (ido) inhibitors
CN111727042A (zh) * 2017-12-06 2020-09-29 仁新医药私人有限公司 微管蛋白抑制剂

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3845008A (en) * 1973-03-02 1974-10-29 Du Pont Brake lining composition comprising particulate tar residue
US4959363A (en) * 1989-06-23 1990-09-25 Sterling Drug Inc. Quinolonecarboxamide compounds, their preparation and use as antivirals.
AU2569292A (en) * 1992-09-09 1994-03-29 Stackpole Limited Powder metal alloy process
US5332422A (en) * 1993-07-06 1994-07-26 Ford Motor Company Solid lubricant and hardenable steel coating system
AU7811194A (en) * 1993-10-02 1995-05-01 Cerasiv Gmbh Molded article
US5518639A (en) * 1994-08-12 1996-05-21 Hoeganaes Corp. Powder metallurgy lubricant composition and methods for using same
US5641580A (en) * 1995-10-03 1997-06-24 Osram Sylvania Inc. Advanced Mo-based composite powders for thermal spray applications
JP3537286B2 (ja) * 1997-03-13 2004-06-14 株式会社三協精機製作所 焼結含油軸受およびそれを用いたモータ
CA2207579A1 (fr) * 1997-05-28 1998-11-28 Paul Caron Piece frittee a surface anti-abrasive et procede pour sa realisation
US6689424B1 (en) * 1999-05-28 2004-02-10 Inframat Corporation Solid lubricant coatings produced by thermal spray methods
JP4011478B2 (ja) * 2000-11-16 2007-11-21 本田技研工業株式会社 金属摺動部材および内燃機関用ピストンならびにそれらの表面処理方法およびその装置
JP2004124130A (ja) * 2002-09-30 2004-04-22 Fujimi Inc 溶射用粉末及びその製造方法並びに該溶射用粉末を用いた溶射方法
US7300488B2 (en) * 2003-03-27 2007-11-27 Höganäs Ab Powder metal composition and method for producing components thereof
TW200502236A (en) * 2003-03-28 2005-01-16 Hoffmann La Roche Novel pyrido[2,3-d]pyrimidin-7-carboxylic acid derivatives, their manufacture and use as pharmaceutical agents
DE10326769B3 (de) * 2003-06-13 2004-11-11 Esk Ceramics Gmbh & Co. Kg Dauerhafte BN-Formtrennschichten für das Druckgießen von Nichteisenmetallen
US7563748B2 (en) 2003-06-23 2009-07-21 Cognis Ip Management Gmbh Alcohol alkoxylate carriers for pesticide active ingredients
WO2005026156A1 (en) * 2003-09-16 2005-03-24 Astrazeneca Ab Quinazoline derivatives
US7553564B2 (en) * 2004-05-26 2009-06-30 Honeywell International Inc. Ternary carbide and nitride materials having tribological applications and methods of making same
US7968503B2 (en) * 2004-06-07 2011-06-28 Ppg Industries Ohio, Inc. Molybdenum comprising nanomaterials and related nanotechnology
US7687112B2 (en) * 2004-07-14 2010-03-30 Kinetitec Corporation Surface for reduced friction and wear and method of making the same
GB0423554D0 (en) * 2004-10-22 2004-11-24 Cancer Rec Tech Ltd Therapeutic compounds
DE102005001198A1 (de) * 2005-01-10 2006-07-20 H.C. Starck Gmbh Metallische Pulvermischungen
US7575619B2 (en) * 2005-03-29 2009-08-18 Hitachi Powdered Metals Co., Ltd. Wear resistant sintered member
US7470307B2 (en) * 2005-03-29 2008-12-30 Climax Engineered Materials, Llc Metal powders and methods for producing the same
TW200801513A (en) 2006-06-29 2008-01-01 Fermiscan Australia Pty Ltd Improved process
US8048892B2 (en) * 2006-12-18 2011-11-01 Amgen Inc. Azaquinolone based compounds exhibiting prolyl hydroxylase inhibitory activity, compositions, and uses thereof
FR2917413B1 (fr) 2007-06-13 2009-08-21 Sanofi Aventis Sa Derives de 7-alkynyl-1,8-naphthyridones, leur preparation et leur application en therapeutique
FR2917412B1 (fr) 2007-06-13 2009-08-21 Sanofi Aventis Sa Derives de 7-alkynyl, 1,8-naphthyridones, leur preparation et leur application en therapeutique
WO2010000020A1 (en) 2008-06-30 2010-01-07 Cathrx Ltd A catheter
FR2933701A1 (fr) * 2008-07-08 2010-01-15 Sanofi Aventis Derives anticancereux, leur preparation et leur application en therapeutique
FR2933700B1 (fr) 2008-07-08 2010-07-30 Sanofi Aventis Derives de pyridino-pyridinones, leur preparation et leur application en therapeutique
US8038760B1 (en) * 2010-07-09 2011-10-18 Climax Engineered Materials, Llc Molybdenum/molybdenum disulfide metal articles and methods for producing same

Also Published As

Publication number Publication date
ES2438540T3 (es) 2014-01-17
AR072798A1 (es) 2010-09-22
TW201004955A (en) 2010-02-01
ZA201100210B (en) 2012-03-28
CN102149713A (zh) 2011-08-10
SV2011003800A (es) 2011-04-29
CA2729833A1 (fr) 2010-01-14
CO6341476A2 (es) 2011-11-21
FR2933700B1 (fr) 2010-07-30
CN102149713B (zh) 2013-12-11
JP2011527320A (ja) 2011-10-27
ECSP11010742A (es) 2011-02-28
MY149705A (en) 2013-09-30
FR2933700A1 (fr) 2010-01-15
MX2011000330A (es) 2011-04-05
EA201170154A1 (ru) 2011-08-30
EP2315767A2 (fr) 2011-05-04
BRPI0915438A2 (pt) 2015-11-10
AU2009267827A1 (en) 2010-01-14
AU2009267827B2 (en) 2014-01-09
IL210514A0 (en) 2011-03-31
PE20110405A1 (es) 2011-07-04
EP2315767B1 (fr) 2013-09-04
US20110124643A1 (en) 2011-05-26
IL210514A (en) 2013-11-28
UA102858C2 (ru) 2013-08-27
EA019362B1 (ru) 2014-03-31
MA32544B1 (fr) 2011-08-01
HN2011000076A (es) 2013-07-22
JP5606434B2 (ja) 2014-10-15
HK1159108A1 (en) 2012-07-27
UY31971A (es) 2010-02-26
CL2011000048A1 (es) 2011-07-15
KR20110031372A (ko) 2011-03-25
CR11866A (es) 2011-03-14
WO2010004197A2 (fr) 2010-01-14
US8436011B2 (en) 2013-05-07
DOP2011000008A (es) 2011-02-15
NZ590862A (en) 2012-06-29
WO2010004197A3 (fr) 2010-03-11

Similar Documents

Publication Publication Date Title
NI201100011A (es) Derivados de piridino - piridinonas, su preparación y su aplicación en terapéutica.
ECSP099791A (es) Derivados de 7-alquinil-1,8-naftiridonas, su preparación y su aplicación en terapéutica
ECSP14013245A (es) Nuevos derivados dihidroquinolina-2-ona
UY31183A1 (es) Derivados de pirazinona y procesos para su preparación
UY33427A (es) Derivados de carbamatos de hexafluoroisopropilo, su preparacion y su aplicacion en terapeutica
CO6491116A2 (es) Derivados de 5-fluoropirimidinona
ECSP10010206A (es) Inhibidores de la replicación del virus de la imunodeficiencia humana
CL2011002825A1 (es) Compuestos derivados de bencimidazol heteroarilo sustituido; composición farmacéutica que los comprende; y su uso en el tratamiento de la hepatitis c.
SV2010003617A (es) Fungicidas
UY32553A (es) Nuevos derivados de la pirrolidinadiona espiroheterocíclicos 3-sustituidos
UY31689A1 (es) Derivados de platino-carbeno n-heterocíclico, su preparación y su aplicación en terapéutica
UY32517A (es) Derivados de nicotinamida, su preparación y su aplicación en terapéutica
ECSP12011651A (es) Derivados de 5-fluoro-2-oxopirimidina-1(2h)-carboxilato
CR20110381A (es) Antagonistas de 4-azetidinil-1-heteroaril-ciclohexanol de ccr2
ECSP12011653A (es) Derivados de n1-acil-5-fluoropirimidinona
UA107671C2 (en) N1-substityted-5-fluoro-2-oxopyrimidinone-1(2h)-carboxamide derivatives
NI201000023A (es) Derivados de indol-2-ona disustituidos en 3, su preparación y su aplicación en terapéutica.
UY29040A1 (es) Procedimiento de amino-tropano, su preparación y aplicación en terapéutica
MX2012010127A (es) Derivados de aminoindanos, su preparacion y su aplicacion en terapeuticos.
NI201000215A (es) NUEVOS DERIVADOS DE (PIPERAZINILO CON ENLACES PUENTE )- 1 - ALCANONA Y SU UTILIZACIÓN COMO INHIBIDORES DE p75.
UY32348A (es) DERIVADOS DE 6-CICLOAMINO-2-TIENIL-3-(PIRIDIN-4-IL)IMIDAZO[1,2-b]-PIRIDAZINA Y 6-CICLOAMINO-2-FURANIL-3-(PIRIDIN-4-IL)IMIDAZO[1,2-b]-PIRIDAZINA, SU PREPARACIÓN Y SU APLICACIÓN EN TERAPEUTICA
UY32843A (es) Octasacáridos n-acilos activadores de los receptores de los fgf, su preparación y su aplicación en terapéutica
DOP2012000146A (es) Nuevos derivados (heterociclo-tetrahidro-piridin)-(piperazinil)-1-alcanona y (heterociclo-dihidro-pirrolidin)-(piperazinil)-1-alcanona y su utilizacion como inhibidores de p75
UY32575A (es) Derivados de 1h-pirazolo[4,3-c]isoquinoleínas, su preparación y su aplicación en terapéutica
SV2008003052A (es) Dimeros de derivados de artemisinina, su preparacion y su aplicacion en terapeutica